Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study.

about

Comparative Study of Liraglutide and Insulin Glargine on Glycemic Control and Pancreatic β-Cell Function in db/db Mice.

P2860

Q54088300-058F7777-3635-48C3-BF77-FAEB95279F0B

P2860

Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study.

Item

http://www.wikidata.org/entity/Q38721614

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Which Patients Will Benefit fr ...... of the Lantus Registry Study.

@en

type

Item

label

Which Patients Will Benefit fr ...... of the Lantus Registry Study.

@en

prefLabel

Which Patients Will Benefit fr ...... of the Lantus Registry Study.

@en

P1476

Which Patients Will Benefit fr ...... s of the Lantus Registry Study

@en

P2093

Lantus Registry Study Group

http://www.w3.org/2001/XMLSchema#string

Shi Bu

http://www.w3.org/2001/XMLSchema#string

Wenying Yang

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Xing

http://www.w3.org/2001/XMLSchema#string

Xuelian Zhang

http://www.w3.org/2001/XMLSchema#string

Ying Shuai

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia.

Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes.

Associations among body mass index, insulin resistance, and pancreatic β-cell function in Korean patients with new-onset type 2 diabetes

Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion?

Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice

Hypoglycemic events and glycosylated hemoglobin values in patients with type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination products.

Clinical study of treatment switching from premixed insulin to basal insulin combined with oral hypoglycemic drugs in patients with type 2 diabetes.

Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients.

P2888

s13300-017-0284-1

P304

887-898

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13300-017-0284-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Haiqing Zhu

P577

2017-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1086042905

http://www.w3.org/2001/XMLSchema#string

P698

28623551

http://www.w3.org/2001/XMLSchema#string

P932

5544620

http://www.w3.org/2001/XMLSchema#string

Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study.

about

P2860

P2860

Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932